Method of detecting antibodies and antibody-hiv virion complexes
OwnerGeorgia Tomaras, Barton F. Haynes +3inventors
InventorsGeorgia Tomaras, Barton F. Haynes, Liu Pinghuang, Nicole Yates, Kwan-Ki Hwang
Life of this patent
Estimating the term…
Abstract
The present invention relates, in general, to HIV and, in particular to a method of detecting anti-HIV antibodies and antibody-HIV virion complexes.
Claims21
A method of identifying a subject who is positive for HIV RNA but negative for anti-HIV antibodies comprising:
- i) obtaining a biological sample from said subject,
- ii) contacting said sample with anti-IgM;
- anti-IgG, anti-IgA or anti-C3D antibodies bound to a solid support under conditions such that antibody-HIV virion complexes present in said sample can bind to said antibodies,
- iii) washing said solid support under conditions such that uncomplexed HIV virion is removed,
- iv) treating said solid support under conditions such that viral RNA from antibody-HIV virion complexes bound to said solid support can be measured, and
- v) assaying for viral RNA resulting from step (iv),
- wherein the presence of said viral RNA indicates said subject is positive for HIV RNA but negative for anti-HIV antibodies.
A method of detecting antibody-HIV virion complexes in a subject comprising:
- i) obtaining a biological sample from said subject,
- ii) contacting said sample with anti-IgM, anti-IgG, anti-IgA or anti-C3D antibodies bound to a solid support under conditions such that antibody-HIV virion complexes present in said sample can bind to said antibodies,
- iii) washing said solid support under conditions such that uncomplexed HIV virion is removed,
- iv) treating said solid support under conditions such that viral RNA from antibody-HIV virion complexes bound to said solid support can be measured, and
- v) assaying for viral RNA resulting from step (iv), and thereby effecting said detection.
A purified antibody having the variable heavy and variable light chains of C14-2 shown in FIG. 15F, or scFv, Fv, Fab′, Fab or F(ab′)2 fragment thereof.
A purified antibody having the heavy chain of F3 shown in FIG. 15K, or scFv, Fv, Fab′, Fab or F(ab′)2 fragment thereof.
Dependencies are inferred from the claim text.